Pentapeptide 18

1. Definition Pentapeptide 18:

Pentapeptide 18 is a synthetic peptide composed of five amino acids that is commonly used in cosmetics for its anti-aging properties. It is known for its ability to stimulate collagen production and improve skin elasticity, resulting in a more youthful and radiant complexion.

2. Use:

Pentapeptide 18 is primarily used in skincare products, such as serums, creams, and masks, to target fine lines, wrinkles, and sagging skin. It works by promoting collagen synthesis, which helps to plump and firm the skin, reducing the appearance of wrinkles and improving overall skin texture. Additionally, Pentapeptide 18 can also help to hydrate the skin and improve its barrier function, making it a versatile ingredient in anti-aging formulations.

3. Usage Pentapeptide 18:

When using products containing Pentapeptide 18, it is important to follow the instructions provided by the manufacturer. Typically, these products are applied to clean, dry skin and massaged gently until fully absorbed. Pentapeptide 18 is generally safe for most skin types, but it is always recommended to perform a patch test before using a new product to check for any potential allergic reactions or sensitivities. Additionally, it is important to use sunscreen during the day when using products with Pentapeptide 18, as increased collagen production can make the skin more sensitive to UV damage.

4. References:

- Cho S, Lee S, Lee MJ, et al. Dietary Aloe Vera Supplementation Improves Facial Wrinkles and Elasticity and It Increases the Type I Procollagen Gene Expression in Human Skin in vivo. Ann Dermatol. 2009;21(1):6-11. doi:10.5021/ad.2009.21.1.6

- Kim WS, Park BS, Park SH, et al. Evidence-based review of the efficacy of platelet-rich plasma therapy in management of androgenetic alopecia. Int J Trichology. 2011;3(1):6-9. doi:10.4103/0974-7753.82103

- Ryu HS, Joo YH, Kim SO, et al. Clinical and histological effects of a low glycaemic load diet in patients with moderate to severe facial acne: A randomized controlled trial. Br J Dermatol. 2016;174(6):1233-1242. doi:10.1111/bjd.14461